Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
A Multicenter, Randomized Phase II Trial Assessing the Activity of Gemcitabine - Oxaliplatin
Chemotherapy Alone or in Combination with Cetuximab in Patients with Advanced Biliary Cancer.